United States · What does Xontogeny invest in?
Xontogeny says it invests in Gene Therapy, Psychedelic and Cbd.
What they do
We are a life sciences accelerator that collaborates with entrepreneurs, scientific founders and first-time CEOs to drive the successful development of their technologies to enable new treatment options for patients with serious disease.From their own website
- Type
- Accelerator (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries B
- Sectors
- Gene TherapyPsychedelicCbd
- Based in
- Boston, United States
- Cold pitches
- Not accepted
The record
No rounds observed yet. That is a limit of the sources we read, not a finding about the firm. If it has invested, a round will put it here. Know a round it was in? Tell us.
The team
We hold 8 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
13 of 21 we have independently watched raise
AalphabioAdaptilensApogeetherapeuticsAvalynpharmaCerevascDelveForgebiologicsLandosbiopharmaLianbioSolidbioSurfTellustherapeuticsVivosenseMercybioMeridabioNephrodiPerceptive AdvisorsPeroxitechSermonixpharmaTorlbioZucara
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.